Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-25 6:52 pm Sale | 13G | SPRUCE BIOSCIENCES INC SPRB | Rosalind Advisors Inc. | 1,508,419 3.67% | -813,581 (-35.04%) | View |
| 2024-03-28 9:15 pm Sale | 13D | SPRUCE BIOSCIENCES INC SPRB | Novo Holdings A/S | 1,656,000 3.9% | -1,100,000 (-39.91%) | View |
| 2024-03-28 12:42 pm Purchase | 13G | SPRUCE BIOSCIENCES INC SPRB | Radoff Bradley Louis | 2,825,000 6.9% | 2,825,000 (New Position) | View |
| 2024-03-25 9:48 pm Sale | 13D | SPRUCE BIOSCIENCES INC SPRB | Novo Holdings A/S | 2,756,000 6.4% | -1,915,021 (-41.00%) | View |
| 2024-03-20 9:31 pm Sale | 13D | SPRUCE BIOSCIENCES INC SPRB | Novo Holdings A/S | 4,671,021 10.9% | -1,794,999 (-27.76%) | View |
| 2024-03-18 9:16 pm Sale | 13D | SPRUCE BIOSCIENCES INC SPRB | Novo Holdings A/S | 6,466,020 15.1% | -1,912,316 (-22.82%) | View |
| 2024-03-07 4:07 pm Unchanged | 13D | SPRUCE BIOSCIENCES INC SPRB | HealthCap VIII L.P. | 3,685,621 8.9% | 0 (Unchanged) | View |
| 2024-02-14 4:57 pm Sale | 13G | SPRUCE BIOSCIENCES INC SPRB | CITADEL ADVISORS LLC | 108,240 0.3% | -1,639,151 (-93.81%) | View |
| 2024-02-14 3:54 pm Purchase | 13G | SPRUCE BIOSCIENCES INC SPRB | ARMISTICE CAPITAL LLC | 2,230,000 5.48% | 2,230,000 (New Position) | View |
| 2024-02-14 2:11 pm Purchase | 13G | SPRUCE BIOSCIENCES INC SPRB | Rock Springs Capital Management LP | 2,609,125 6.41% | 986,436 (+60.79%) | View |
| 2024-02-06 4:15 pm Purchase | 13G | SPRUCE BIOSCIENCES INC SPRB | Aisling Capital V LP | 1,205,511 3% | 1,205,511 (New Position) | View |
| 2024-01-30 11:06 am Purchase | 13G | SPRUCE BIOSCIENCES INC SPRB | Rosalind Advisors Inc. | 2,322,000 5.67% | 2,322,000 (New Position) | View |
| 2023-05-30 4:48 pm Purchase | 13D | SPRUCE BIOSCIENCES INC SPRB | RiverVest Venture Fund III L.P. | 3,527,281 8.6% | 1,379,000 (+64.19%) | View |
| 2023-02-27 4:00 pm Purchase | 13G | SPRUCE BIOSCIENCES INC SPRB | 5AM Opportunities II L.P. | 4,137,000 9.97% | 4,137,000 (New Position) | View |
| 2023-02-23 4:15 pm Purchase | 13D | SPRUCE BIOSCIENCES INC SPRB | Carlyle Group Inc. CG | 3,734,518 9.2% | 1,932,000 (+107.18%) | View |
| 2023-02-21 4:28 pm Purchase | 13D | SPRUCE BIOSCIENCES INC SPRB | Novo Holdings A/S | 8,378,336 19.9% | 3,864,000 (+85.59%) | View |
| 2023-02-14 2:56 pm Unchanged | 13G | SPRUCE BIOSCIENCES INC SPRB | Rock Springs Capital Management LP | 1,622,689 6.89% | 0 (Unchanged) | View |
| 2023-02-14 08:02 am Purchase | 13G | SPRUCE BIOSCIENCES INC SPRB | CITADEL ADVISORS LLC | 1,747,391 7.4% | 12,322 (+0.71%) | View |
| 2023-02-13 4:16 pm Purchase | 13D | SPRUCE BIOSCIENCES INC SPRB | HealthCap VIII L.P. | 3,685,621 8.9% | 1,652,000 (+81.23%) | View |
| 2022-09-30 4:54 pm Unchanged | 13D | SPRUCE BIOSCIENCES INC SPRB | Novo Holdings A/S | 4,514,336 19.2% | 0 (Unchanged) | View |